Physician profile
Peter Michael Lipscomb
NPI 1437598273
$2,055.30
in general payments reported to CMS, 2019-2025
23 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $155 · 2021: $208 · 2022: $271 · 2023: $327 · 2024: $263 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $399.90 | 2019-2025 | |
| Thea Pharma INC. | $382.77 | 2023-2025 | Iyuzeh |
| Alcon Vision LLC | $352.68 | 2019-2025 | Clareon, Ngenuity, Simbrinza |
| Johnson & Johnson Surgical Vision, INC. | $161.34 | 2022 | |
| Abbvie INC. | $99.30 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $77.97 | 2019-2021 | |
| Allergan, INC. | $73.24 | 2019-2022 | |
| Oyster Point Pharma, INC. | $70.37 | 2023-2024 | Tyrvaya |
| Lensar, INC. | $51.59 | 2025 | Lensar Laser System |
| Notal Vision, INC. | $50.41 | 2025 | Foresee Home |
| Rayner Intraocular Lenses Limited | $47.48 | 2023 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.44 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $38.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.50 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $25.96 | 2025 | Xdemvy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $23.57 | 2023 | Miebo |
| Sight Sciences, INC. | $21.75 | 2022 | |
| Biotissue Holdings INC. | $21.41 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2023 | Veracity Surgical |
| Rxsight INC | $17.84 | 2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Shire North American Group INC | $17.56 | 2019 | |
| Omeros Corporation | $12.44 | 2019 | |
| Eyepoint US, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lipscomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.